Back

Circulating mitochondrial and metabolic biomarkers in HFpEF: from energetic failure to clinical prediction - a systematic review

9 May 2026 (13:50 - 15:10)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - biomarkers (4) Biomarkers HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Ms Shrinika Satishkumar

Tbilisi (Georgia)

5 More presentations in this session

Presentation thumbnail
Prevalence of potential primary aldosteronism in patients with heart failure with reduced ejection fraction: a post hoc analysis of the ALOFT trial
Doctor M. Chimura (Glasgow, GB)
Abstract Slides
Presentation thumbnail
Do endothelial markers possess a role in the evaluation of decongestion and prediction of adverse cardiovascular events in hospitalised patients with acute decompensated heart failure?
Doctor J. Jurica (Martin, SK)
Abstract Slides
Presentation thumbnail
SuPAR, a new prognostic marker in acute heart failure with reduced ejection fraction?
Doctor A. Bollas Becerra (Madrid, ES)
Abstract Slides
Presentation thumbnail
FGF-23 in acute heart failure with reduced ejection fraction: is it useful to predict admissions?
Doctor A. Bollas Becerra (Madrid, ES)
Abstract Slides
Presentation thumbnail
Association between soluble ST2 levels and pulmonary congestion in heart failure
Doctor M. Kobayashi (Tokyo, JP)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - biomarkers (4)

The Event

Event poster

Heart Failure 2026

9 May 2026 13:50 CET
You may be interested in
thumbnail
Congress Session
From genetic signatures to clinical implications
thumbnail
Congress Presentation
A proteo-genomic discovery approach to identify markers of early heart failure
thumbnail
Congress Presentation
State-of-the-art lecture on current state of the diagnosis of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources